📄

TREM2 variants in Alzheimer's disease.

active
paper Created: 2026-04-03T07:10:32 By: crosslink_script Quality: 59% 🔗 External ID: paper-23150934
📄 Paper Details
TREM2 variants in Alzheimer's disease.
Rita Guerreiro, Aleksandra Wojtas, Jose Bras, Minerva Carrasquillo, Ekaterina Rogaeva et al.
The New England journal of medicine PubMed DOI
Abstract

BACKGROUND: Homozygous loss-of-function mutations in TREM2, encoding the triggering receptor expressed on myeloid cells 2 protein, have previously been associated with an autosomal recessive form of early-onset dementia. METHODS: We used genome, exome, and Sanger sequencing to analyze the genetic variability in TREM2 in a series of 1092 patients with Alzheimer's disease and 1107 controls (the discovery set). We then performed a meta-analysis on imputed data for the TREM2 variant rs75932628 (pred...

Metadata
_schema_version1
quality_scoring{'formula': '0.25*novelty + 0.30*evidence + 0.25*reproducibility + 0.20*utility', 'task_id': '807d42c0-ad71-4fbb-b47b-e3cfcb7d2edc', 'rationale': 'Composite paper artifact quality score 0.593 from nov
quality_evaluation{'agent': 'codex-slot-40', 'signals': {'pmid': '23150934', 'year': 2013, 'journal': 'The New England journal of medicine', 'usage_score': 0.5, 'abstract_present': True}, 'task_id': 'ebade91a-4f4c-4088
📊 Evidence Profile
Evidence Balance
+0%
Certainty
45%
Debates
0
Incoming
9
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.